Brown Brothers Harriman & Co’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $320K | Sell |
3,354
-20
| -0.6% | -$1.92K | ﹤0.01% | 778 |
|
|
2026
Q1 | $350K | Buy |
3,374
+1,316
| +64% | +$149K | ﹤0.01% | 704 |
|
|
2025
Q4 | $208K | Buy |
2,058
+1,107
| +116% | +$120K | ﹤0.01% | 746 |
|
|
2025
Q3 | $117K | Sell |
951
-1,008
| -51% | -$125K | ﹤0.01% | 814 |
|
|
2025
Q2 | $235K | Buy |
1,959
+1,519
| +345% | +$203K | ﹤0.01% | 601 |
|
|
2025
Q1 | $64.8K | Sell |
440
-26
| -6% | -$3.97K | ﹤0.01% | 787 |
|
|
2024
Q4 | $75.7K | Buy |
466
+43
| +10% | +$7.03K | ﹤0.01% | 787 |
|
|
2024
Q3 | $68.9K | Buy |
423
+28
| +7% | +$4.15K | ﹤0.01% | 753 |
|
|
2024
Q2 | $53.9K | Sell |
395
-170
| -30% | -$23.6K | ﹤0.01% | 753 |
|
|
2024
Q1 | $86.5K | Sell |
565
-575
| -50% | -$85.8K | ﹤0.01% | 670 |
|
|
2023
Q4 | $163K | Sell |
1,140
-224
| -16% | -$29.9K | ﹤0.01% | 530 |
|
|
2023
Q3 | $179K | Sell |
1,364
-34
| -2% | -$5.17K | ﹤0.01% | 499 |
|
|
2023
Q2 | $222K | Sell |
1,398
-1
| -0.1% | -$161 | ﹤0.01% | 456 |
|
|
2023
Q1 | $221K | Sell |
1,399
-111
| -7% | -$16.6K | ﹤0.01% | 471 |
|
|
2022
Q4 | $212K | Hold |
1,510
| – | – | ﹤0.01% | 459 |
|
|
2022
Q3 | $194K | Sell |
1,510
-36
| -2% | -$5.2K | ﹤0.01% | 473 |
|
|
2022
Q2 | $218K | Buy |
1,546
+50
| +3% | +$7.14K | ﹤0.01% | 446 |
|
|
2022
Q1 | $208K | Sell |
1,496
-543
| -27% | -$83.2K | ﹤0.01% | 500 |
|
|
2021
Q4 | $356K | Sell |
2,039
-309
| -13% | -$51.5K | ﹤0.01% | 384 |
|
|
2021
Q3 | $389K | Hold |
2,348
| – | – | ﹤0.01% | 357 |
|
|
2021
Q2 | $422K | Buy |
2,348
+9
| +0.4% | +$1.64K | ﹤0.01% | 334 |
|
|
2021
Q1 | $451K | Buy |
2,339
+160
| +7% | +$30.8K | ﹤0.01% | 304 |
|
|
2020
Q4 | $440K | Sell |
2,179
-141
| -6% | -$29.2K | ﹤0.01% | 324 |
|
|
2020
Q3 | $488K | Sell |
2,320
-200
| -8% | -$44.5K | ﹤0.01% | 266 |
|
|
2020
Q2 | $553K | Sell |
2,520
-710
| -22% | -$142K | ﹤0.01% | 252 |
|
|
2020
Q1 | $560K | Sell |
3,230
-86
| -3% | -$14.2K | ﹤0.01% | 237 |
|
|
2019
Q4 | $509K | Sell |
3,316
-96
| -3% | -$14.3K | ﹤0.01% | 308 |
|
|
2019
Q3 | $518K | Buy |
3,412
+18
| +0.5% | +$2.85K | ﹤0.01% | 287 |
|
|
2019
Q2 | $520K | Buy |
3,394
+8
| +0.2% | +$1.22K | ﹤0.01% | 277 |
|
|
2019
Q1 | $543K | Buy |
3,386
+22
| +0.7% | +$3.41K | ﹤0.01% | 255 |
|
|
2018
Q4 | $519K | Sell |
3,364
-205
| -6% | -$31.9K | ﹤0.01% | 241 |
|
|
2018
Q3 | $537K | Buy |
3,569
+200
| +6% | +$28.4K | ﹤0.01% | 242 |
|
|
2018
Q2 | $456K | Hold |
3,369
| – | – | ﹤0.01% | 244 |
|
|
2018
Q1 | $448K | Sell |
3,369
-24
| -0.7% | -$3.22K | ﹤0.01% | 252 |
|
|
2017
Q4 | $505K | Sell |
3,393
-17
| -0.5% | -$2.31K | ﹤0.01% | 240 |
|
|
2017
Q3 | $450K | Sell |
3,410
-115
| -3% | -$15.5K | ﹤0.01% | 235 |
|
|
2017
Q2 | $470K | Sell |
3,525
-250
| -7% | -$33.7K | ﹤0.01% | 231 |
|
|
2017
Q1 | $509K | Hold |
3,775
| – | – | ﹤0.01% | 222 |
|
|
2016
Q4 | $453K | Sell |
3,775
-450
| -11% | -$53.1K | ﹤0.01% | 221 |
|
|
2016
Q3 | $529K | Buy |
4,225
+426
| +11% | +$55.8K | ﹤0.01% | 212 |
|
|
2016
Q2 | $526K | Sell |
3,799
-231
| -6% | -$30K | ﹤0.01% | 222 |
|
|
2016
Q1 | $508K | Sell |
4,030
-300
| -7% | -$38.1K | ﹤0.01% | 226 |
|
|
2015
Q4 | $549K | Buy |
4,330
+300
| +7% | +$37.2K | ﹤0.01% | 227 |
|
|
2015
Q3 | $466K | Hold |
4,030
| – | – | ﹤0.01% | 245 |
|
|
2015
Q2 | $419K | Buy |
4,030
+132
| +3% | +$14.2K | ﹤0.01% | 270 |
|
|
2015
Q1 | $430K | Sell |
3,898
-1,466
| -27% | -$159K | ﹤0.01% | 274 |
|
|
2014
Q4 | $559K | Hold |
5,364
| – | – | ﹤0.01% | 244 |
|
|
2014
Q3 | $515K | Hold |
5,364
| – | – | ﹤0.01% | 256 |
|
|
2014
Q2 | $490K | Sell |
5,364
-137
| -2% | -$12.3K | ﹤0.01% | 266 |
|
|
2014
Q1 | $484K | Buy |
5,501
+2,569
| +88% | +$226K | ﹤0.01% | 247 |
|
|
2013
Q4 | $272K | Buy |
2,932
+1,466
| +100% | +$132K | ﹤0.01% | 358 |
|
|
2013
Q3 | $120K | Hold |
1,466
| – | – | ﹤0.01% | 373 |
|
|
2013
Q2 | $122K | Buy |
+1,466
| New | +$126K | ﹤0.01% | 436 |
|
Other funds holding CLX
Brown Brothers Harriman & Co's CLX Position: Q2 2026 in Review
Brown Brothers Harriman & Co reduced its Clorox (CLX) stake by 0.59% in Q2 2026, selling an estimated $1.92K and leaving 3,354 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #778.
Brown Brothers Harriman & Co first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $560K in Q1 2020. 1,044 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Brown Brothers Harriman & Co held 3,354 shares of Clorox worth $320K as of Q2 2026.
- Brown Brothers Harriman & Co sold 20 Clorox shares in Q2 2026, an estimated $1.92K.
- Clorox made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #778 holding.
- Brown Brothers Harriman & Co first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
- Brown Brothers Harriman & Co's Clorox position peaked at $560K in Q1 2020.
- 1,044 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.